For the first time in modern U.S. cannabis policy, you can legally import or export medical marijuana products — provided you hold a cannabis import export permit. The DEA’s April 22, 2026 Final Order amended 21 CFR § 1312.30 to add three new categories of Schedule III non-narcotic controlled substances to the import-export permit list. Every cross-border shipment of FDA-approved marijuana drug products, marijuana extracts, and naturally derived Δ9-THC now needs a permit before it moves.

cannabis import export permit
Cannabis import export permit under 21 CFR § 1312.30.

This post walks through the cannabis import export permit mechanics — DEA Form 357 (import), DEA Form 161 (export), the Article 31 Single Convention trigger, the quotas, and the six critical steps to land a permit. For the broader federal-cover picture, see our pillar on the federal cannabis license and the operational walkthrough on DEA cannabis registration.

Why a cannabis import export permit suddenly exists

The reason is treaty law. The United States is a party to the Single Convention on Narcotic Drugs, which at Article 31 requires parties to license importers and exporters of cannabis (a Schedule I treaty drug) and to predicate every individual import or export on a permit. The Final Order moves marijuana products to Schedule III of U.S. domestic law, but cannabis remains Schedule I under the treaty. To stay in compliance with Article 31 obligations, DEA had to keep the permit requirement in place — and that meant amending § 1312.30 to add the rescheduled products to the list of Schedule III non-narcotic substances that require an import-export permit.

Translation: the cannabis import export permit isn’t a new bureaucratic invention. It’s the U.S. wiring its domestic regulations back to a treaty obligation that never went away.

What § 1312.30 now covers

The amendment to § 1312.30 adds three new paragraphs (b), (c), and (d), bringing into permit scope:

  • Marijuana as defined in 21 U.S.C. § 802(16), in an FDA-approved drug product or subject to a state medical marijuana license
  • Marijuana extract as defined in 21 CFR § 1308.11(d)(58), in an FDA-approved drug product or subject to a state medical marijuana license
  • Naturally derived delta-9-tetrahydrocannabinols in an FDA-approved drug product or subject to a state medical marijuana license — meaning Δ9-THC naturally contained in a cannabis plant, excluding hemp under 7 U.S.C. § 1639o and excluding synthetic THC

If a product fits any of those three buckets, every cross-border movement requires a cannabis import export permit before the shipment moves. No permit, no shipment.

The forms — DEA Form 357 and DEA Form 161

Two forms, two directions, both run through DEA’s Diversion Control Division.

  • DEA Form 357 — Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes. Use this to bring an FDA-approved marijuana drug product or state-medical-license cannabis material across the border into the United States. Statutory authority: 21 U.S.C. § 952; procedural rules at 21 CFR §§ 1312.11 and 1312.12.
  • DEA Form 161 — Application for Permit to Export Controlled Substances. Use this to ship an FDA-approved marijuana drug product or state-medical-license cannabis material from the U.S. to a destination country. Statutory authority: 21 U.S.C. § 953; procedural rules at 21 CFR §§ 1312.21 and 1312.22.

For active-pharmaceutical-ingredient (API) imports tied to FDA-approved drug manufacturing, DEA Form 161R is the registered manufacturer/researcher analog. The Diversion Control online portal at deadiversion.usdoj.gov/imp_exp handles all three.

Step 1: Confirm the underlying registration before you touch a permit

You cannot apply for a cannabis import export permit unless you already hold a DEA registration as an importer, exporter, manufacturer, or researcher. The § 1301.13(k) state-medical pathway provides that registration for entities holding a state medical marijuana license. If you’re trying to import cannabis material as a research sponsor, you’ll register under § 1301.13 as a researcher. Either way, the registration precedes the permit.

The order makes this explicit at 21 U.S.C. § 957: every importer or exporter of a Schedule III non-narcotic controlled substance must be registered with DEA as an importer or exporter for that schedule. The cannabis import export permit pathway is open only to registrants. Plan accordingly.

Step 2: Reconcile the permit scope to the underlying state license

Section 1301.13(k)(3) caps your DEA cannabis registration at the scope of your state license. That cap flows through to your permit. If your state license authorizes only manufacturing for in-state distribution, your federal registration cannot authorize export of finished product. If your state license authorizes import of API for processing, your federal permit can support that.

Map the scope question before you file. The permit application requires you to declare the consignor, the consignee, the substance, the quantity, the source country (for imports) or destination country (for exports), the port of entry/exit, the carrier, and the projected dates of shipment. Every one of those declarations must align with both your state license and your federal registration. A mismatch is a denial.

Step 3: Quotas — the often-missed prerequisite

Schedule III cannabis material is subject to 21 U.S.C. § 826 quota provisions because the United States must comply with Single Convention Articles 19, 20, and 21 — annual estimates and quota requirements for narcotic drugs. The Order’s discussion of “Existing State Regulatory Systems” and the § 1318.06(a) administrative-fee mechanism both reference this quota framework.

Before DEA issues a cannabis import export permit, the agency must confirm that the volume requested fits inside the U.S.’s submitted INCB estimate for that substance for that calendar year. Manufacturers should be filing quota applications well in advance of any planned import or export. A cannabis compliance team can help model your annual demand and prepare the quota submission alongside the permit application.

Step 4: The single-shipment rule — and why blanket permits don’t exist

Article 31 of the Single Convention requires that “each individual importation or exportation” be predicated on the issuance of a permit. DEA implements that requirement strictly: a cannabis import export permit covers one shipment, identified by consignor, consignee, substance, quantity, and time window. There is no blanket import permit. There is no annual export permit. Each shipment, each filing, each permit.

For commercial operators planning regular cross-border movement — say, a U.S. medical cannabis manufacturer exporting to a licensed buyer in Germany or Israel — the operational rhythm is permit-application, shipment, permit-application, shipment. Build that cadence into your sales operations from day one.

Step 5: Plan for the destination country’s import permit too

A U.S. cannabis import export permit only resolves the U.S. side. The receiving country is a separate party to the Single Convention with its own Article 31 obligations. Germany requires a BfArM import permit. Canada requires a Health Canada import permit. Israel requires a Ministry of Health permit. Australia requires an Office of Drug Control permit.

Practically, cross-border cannabis shipments need two permits before they move — the DEA Form 161 from the U.S. side and the equivalent permit from the destination country’s competent authority. The two permits are typically tied: the destination country’s permit references the U.S. export permit number, and DEA references the destination-country import authorization in its Form 161 review. Plan an extra 30–60 days for the foreign-side filing.

Step 6: Recordkeeping, INCB reporting, and the audit trail

Every cannabis import export permit creates a long-lived recordkeeping obligation. Under 21 U.S.C. § 827 and 21 CFR § 1304.21 et seq., importers and exporters must maintain shipment records for at least two years — and the actual horizon for treaty-side reporting under Single Convention Article 20 (statistical returns on imports, exports, and seizures) runs longer. DEA forwards the U.S. side of those returns to the International Narcotics Control Board annually.

Operationally, your compliance file for each cross-border shipment should include: the filed Form 357 or 161, the granted permit number, the destination-country authorization, the bill of lading or air waybill, the customs entry documents, the carrier’s chain-of-custody records, the consignee’s receipt confirmation, and the next-cycle quota reconciliation. If any of those records are missing when DEA audits, the consequence runs from administrative warning to permit revocation to criminal liability under 21 U.S.C. § 960.

What’s NOT now permitted across borders

The cannabis import export permit pathway is narrow. It covers FDA-approved marijuana drug products, marijuana extracts in those products or under state medical license, and naturally derived Δ9-THC under the same conditions. Read the exclusions carefully:

  • Adult-use cannabis stays in Schedule I. No permit pathway exists for adult-use product — period.
  • Unlicensed bulk marijuana stays in Schedule I. Grey-market export-by-courier isn’t suddenly legal.
  • Synthetic THC is excluded. Delta-10, synthetic delta-9, and tetrahydrocannabinols derived through artificial synthesis don’t qualify.
  • Hemp is unaffected — but watch the November 12, 2026 amendment to 7 U.S.C. § 1639o redefining hemp around “total tetrahydrocannabinols concentration.” That’s a separate earthquake we’ll cover separately.
  • Interstate U.S. commerce remains blocked. A cannabis import export permit moves product across the U.S. border. State-to-state shipments inside the U.S. still depend on whether your state license authorizes interstate commerce — and most don’t.

Who actually needs to be filing this week

Three operator profiles should be on a cannabis import export permit track right now.

  1. FDA-approved drug sponsors. Companies developing or marketing FDA-approved drug products that contain marijuana — Epidiolex’s successors, the next generation of cannabinoid pharmaceuticals — already deal in cross-border API and finished-dose movement. Now those movements are inside a clean federal permit framework rather than a pre-rescheduling grey zone.
  2. State medical operators with international supply chains. A handful of state-medical-licensed manufacturers source extracts, isolates, or finished product from licensed operators in Canada, Israel, or the EU. Those supply chains have run on a patchwork of state authorizations and federal forbearance. The cannabis import export permit pathway lets them clean that up.
  3. Research sponsors and university IRB labs. Cross-border movement of research-grade cannabis material — between U.S. universities and international collaborators — finally has a clean permit framework. See our companion post on Schedule III cannabis research registration for the research-side mechanics.

Frequently asked questions about the cannabis import export permit

Do I need a cannabis import export permit for adult-use cannabis?

No, because there is no permit pathway for adult-use cannabis. Adult-use marijuana remains in Schedule I under federal law, and § 1312.30 only covers FDA-approved marijuana drug products and state-medical-license cannabis material. Adult-use cross-border movement remains federally illegal.

What’s the difference between DEA Form 357 and DEA Form 161?

Form 357 is the application for a permit to import controlled substances. Form 161 is the application for a permit to export controlled substances. Form 161R is the export-permit variant for registered manufacturers and researchers. The cannabis import export permit pathway uses Form 357 for import and Form 161 (or 161R) for export.

Can I get a blanket cannabis import export permit?

No. The Single Convention’s Article 31 requires that each individual importation or exportation be predicated on a separate permit. DEA implements that strictly. Each shipment requires its own permit — there is no blanket annual import permit or umbrella export permit.

How long does a cannabis import export permit take to process?

DEA has not published a specific processing timeline for the new § 1312.30 categories, but historical permit processing for Schedule III non-narcotic substances runs 30–60 days from a complete application. Plan an additional 30–60 days for destination-country authorizations on top.

Does the permit move with the shipment?

Yes. The granted permit number must accompany the shipment documentation — bill of lading or air waybill, customs entry papers, and chain-of-custody records. DEA, U.S. Customs and Border Protection, and the destination-country competent authority all rely on the permit number for shipment validation.

What records do I keep after the shipment lands?

Every importer and exporter must keep at least two years of records under 21 U.S.C. § 827 and 21 CFR Part 1304. For treaty-reporting purposes, your annual INCB statistical returns are submitted via DEA. Practically, keep the full file — application, permit, customs documents, foreign authorization, consignee receipt — for at least seven years to support potential audits or inquiries.

Is hemp affected by the new permit rules?

No. Hemp as defined at 7 U.S.C. § 1639o is excluded from the marijuana definition and is not subject to the cannabis import export permit framework. Watch the November 12, 2026 amendment to the hemp definition — it changes the THC measurement standard but does not pull hemp into Schedule III.

Our team is helping operators file this quarter

If you’re sourcing FDA-approved drug product, exporting to a licensed international buyer, or building a research collaboration that requires cross-border movement, we’re helping operators land cannabis import export permits this quarter. Our team handles:

  • Form 357 and Form 161 (or 161R) drafting under § 1312.30
  • Quota application strategy and INCB-aligned demand modeling
  • Destination-country competent-authority coordination (Canada, Germany, Israel, Australia)
  • Recordkeeping system design for 21 CFR Part 1304 compliance
  • Customs and CBP coordination for cleared shipment release

Book a confidential consultation on your cannabis import export permit strategy, or read the rest of our Schedule III rollout coverage. The operators who set up the cross-border permit cadence early will own the international medical-cannabis trade flows for the next decade.

{“@context”:”https://schema.org”,”@type”:”Article”,”headline”:”Cannabis Import Export Permit: 6 Critical DEA Steps After Schedule III”,”description”:”The April 22, 2026 Schedule III order amended 21 CFR 1312.30 to require a cannabis import export permit for every shipment. Here are the 6 critical filing steps.”,”author”:{“@type”:”Person”,”name”:”Thomas Howard”,”url”:”https://cannabisindustrylawyer.com/about/”},”publisher”:{“@type”:”Organization”,”name”:”Cannabis Industry Lawyer”,”url”:”https://cannabisindustrylawyer.com/”},”datePublished”:”2026-04-25″,”dateModified”:”2026-04-25″,”image”:”https://www.cannabisindustrylawyer.com/wp-content/uploads/2026/04/cannabis-import-export-permit.webp”,”mainEntityOfPage”:”https://cannabisindustrylawyer.com/cannabis-import-export-permit/”}

{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[
{“@type”:”Question”,”name”:”Do I need a cannabis import export permit for adult-use cannabis?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”No, because there is no permit pathway for adult-use cannabis. Adult-use marijuana remains in Schedule I under federal law.”}},
{“@type”:”Question”,”name”:”What is the difference between DEA Form 357 and DEA Form 161?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Form 357 is the application for a permit to import controlled substances. Form 161 is the application for a permit to export controlled substances. The cannabis import export permit pathway uses Form 357 for import and Form 161 for export.”}},
{“@type”:”Question”,”name”:”Can I get a blanket cannabis import export permit?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”No. The Single Convention Article 31 requires that each individual importation or exportation be predicated on a separate permit. Each shipment requires its own permit.”}},
{“@type”:”Question”,”name”:”How long does a cannabis import export permit take to process?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Historical permit processing for Schedule III non-narcotic substances runs 30 to 60 days from a complete application. Plan additional time for destination-country authorizations.”}},
{“@type”:”Question”,”name”:”What records do I keep after the shipment lands?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Importers and exporters must keep at least two years of records under 21 USC 827 and 21 CFR Part 1304. Practically keep the full file at least seven years.”}},
{“@type”:”Question”,”name”:”Is hemp affected by the new permit rules?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”No. Hemp as defined at 7 USC 1639o is excluded from the marijuana definition and is not subject to the cannabis import export permit framework.”}}
]}